1 Correction to: Drugs https://doi.org/10.1007/s40265-018-0903-9
An Online First version of this article was made available online at http://link.springer.com/journal/40265/onlineFirst/page/1 on 16 April 2018. Errors were subsequently identified in the article, and the following corrections should be noted:
-
Rewording in main text
Section 1, Introduction, paragraph 3, line 1: The following line, which previously read:
“Apatinib [AiTan™ (China); Rivoceranib® (global)] is a”
Should read:
“Apatinib [Aitan® (brand name in China)], also known as rivoceranib, is a”
The original article has been updated.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scott, L.J. Correction to: Apatinib: A Review in Advanced Gastric Cancer and Other Advanced Cancers. Drugs 78, 759 (2018). https://doi.org/10.1007/s40265-018-0913-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40265-018-0913-7